Education, Science, Technology, Innovation and Life
Open Access
Sign In

Therapeutic Effect of Botulinum Toxin a on Children with Spastic Cerebral Palsy: Meta-analysis

Download as PDF

DOI: 10.23977/aetp.2021.55025 | Downloads: 26 | Views: 905

Author(s)

Chen Tang 1, Yingying Shao 1, Bin Chen 2, Xudong Jiang 3

Affiliation(s)

1 School of Science, Guangxi University of Science and Technology, Liuzhou 545005, Guangxi, China
2 Liuzhou Workers' Hospital, Liuzhou 545005, Guangxi, China
3 School of Medicine, Guangxi University of Science and Technology, Liuzhou 545005, Guangxi, China

Corresponding Author

Xudong Jiang

ABSTRACT

To systematically evaluate the clinical effect of botulinum toxin A (BXT-A) on children with spastic cerebral palsy. All clinical randomized controlled trials (RCTs) of BXT-A in children with spastic cerebral palsy were collected from the database establishment to April 20, 2021. Meta-analysis was performed on the extracted data using Review Manager 5.4 and R 4.0 software. A total of 21 studies met the inclusion criteria, including 1357 cases of spastic cerebral palsy and 704 cases in the BTX-A+ rehabilitation group. Meta-analysis results showed that: MAS score [MD=-0.83, 95%CI (-0.86, -0.80), Z=51.03, P<0.05] and GMFM-88 score [MD=5.50, 95%CI (4.40, 6.59), Z=9.85, P<0.05] in BTX-A+ rehabilitation treatment group, GMFM-D score [MD=8.51, 95%CI (5.24, 11.78), Z=5.09, P<0.05], GMFM-E score [MD=8.44, 95%CI (5.16, 11.72), Z=5.04, P<0.05], CSS score [MD=-1.86, 95%CI (-3.07, -0.66), Z=3.03, P<0.05], PRS score [MD=0.85, 95%CI (0.26, 1.44), Z=2.83, P<0.05] were better than the rehabilitation treatment group in these aspects, and the diversity between the two groups was statistically (P<0.05). BTX-A can effectively enhance motor function, and is an effective method for the treatment of children with spastic cerebral palsy.

KEYWORDS

BXT-A, cerebral palsy, meta-analysis

CITE THIS PAPER

Chen Tang, Yingying Shao, Bin Chen and Xudong Jiang. Therapeutic Effect of Botulinum Toxin a on Children with Spastic Cerebral Palsy: Meta-analysis. Advances in Educational Technology and Psychology (2021) 5: 191-199. DOI: http://dx.doi.org/10.23977/aetp.2021.55025.

REFERENCES

[1] Zhao HL, Li XJ. Research Progress on the Etiology of Cerebral Palsy [J]. Chinese Journal of Rehabilitation Medicine, 2018, 33(03): 369-373.
[2] Neurology Group, Pediatrics Branch. Chinese Medical Association. The Diagnosis of Cerebral Palsy in Children [J]. Chinese Journal of Pediatrics, 2005,43(4): 262
[3] Liu JJ, Ji SR, Wu WH, et al. Effect of Botulinum Toxin Type a on Iliopsoas Spasm in Children With Cerebral Palsy [J]. Chinese Journal of Rehabilitation Theory and Practice, 2013(10): 956-959.
[4] Gao YQ, Niu GH, Wang MM. Effects of Botulinum Toxin Type a Local Injection Combined with Rehabilitation Training on Lower Limb Motor Function and Quality of Life in Children with Spastic Cerebral Palsy [J]. Chinese Journal of Endemic Disease Control, 2017, 32(11): 1289.
[5] Li JL, Xu KS, Yan XH, et al. Effects of Botulinum Toxin Type a on Planar Pressure in Children with Spastic Cerebral Palsy [J].China Rehabilitation, 2015(3): 195-197.
[6] Tian ZX, Yu YZ, Gao BQ, et al. Botulinum Toxin a in the Treatment of Spasmodic Cerebral Palsy Combined With Knee Flexion [J].Beijing Medical Journal, 2010, 32(10): 827-830.
[7] Xu L, Yang YL, Yu HF, et al.Clinical Study of Botulinum Toxin a in the Treatment of lower Limb Movement Disorders in Children with Spastic Hemiplegia Cerebral Palsy [J]. Chinese Journal of Child Health Care, 2008, 16(6): 704-706.
[8] Shao YJ, Wu GH, Liang LF, et al. Effects of Botulinum Toxin Type a Injection on Motor Function in Children with Spastic Cerebral Palsy of Lower Extremities [J]. Diet Health Care, 2018, 5(22): 32.
[9] Wang L, Chen Z, Sun EL. Botulinum Toxin a Injection Combined with Rehabilitation Training in the Treatment of Spastic Cerebral Palsy [J]. Chinese Journal of Applied Neurology, 2014(16): 94-95.
[10] Hou YJ, Shan HJ, Jie XS, et al. Effects of Botulinum Toxin Type a Injection Combined with Functional Training on Children with Spastic Cerebral Palsy with Sharp Foot Deformity, Crude Motor Function and Intelligence Development [J]. Chinese Journal of General Practice, 2017, 20(31): 3912-3917.
[11] Yan H, Zhang HJ, Guo CG, et al. The Effect of Botulinum Toxin Type a Injection on the Development of Acute Foot Deformity and Motor Function in Spastic Cerebral Palsy [J]. Chinese Journal of Rehabilitation Theory and Practice, 2010, 16(11): 1047-1050.
[12] Liang TJ, He XY, Zhang QF. Botulinum Toxin Type a Injection in the Treatment of Lower Limb Spasm in Children with Cerebral Palsy [J]. Journal of Guangxi Medical University, 2012, 29(1): 128-130.
[13] Dong XL, Kong M, Yu ZH, et al. Clinical Observation of Botulinum Toxin a in the Treatment of Spastic Cerebral Palsy [J]. West China Medical Journal, 2008, 23(4): 844-845.
[14] Nigar Dursun, Gokbel T, Akarsu M, Dursun E. Randomized Controlled Trial on Effectiveness of Intermittent Serial Casting on Spastic Equinus Foot in Children with Cerebral Palsy After Botulinum Toxin-A Treatment. Am J Phys Med Rehabil. 2017 Apr; 96(4): 221-225.
[15] M.A. El-Etribi, Salem ME, El-Shakankiry HM, El-Kahky AM, El-Mahboub SM. The Effect of Botulinum Toxin Type-a Injection on Spasticity, Range of Motion and Gait Patterns in Children with Spastic Diplegic Cerebral Palsy: an Egyptian study. Int J Rehabil Res. 2004 Dec; 27(4): 275-81.
[16] Guan LJ, Yan XR, Gao S, et al.Ultrasonic-Localized Intramuscular Injection of Botulinum Toxin a in the Treatment of 30 Patients with Spastic Cerebral Palsy [J]. Pediatrics of Integrated Traditional and Western Medicine, 2011, 03(6): 517-520.
[17] Zhang YJ. Ultrasound-Guided Botulinum Toxin a Injection Combined with Routine Rehabilitation Training in the Treatment of Spastic Cerebral Palsy [D]. Hefei: Anhui Medical University, 2016.
[18] Yi AW, Chang YQ, Liang WY, et al. Ultrasound-guided Botulinum Toxin Injection Combined with Wax Therapy in the Treatment of Lower Limb Spasm in Cerebral Palsy [J]. Chinese Journal of Applied Medicine, 2016, 11(20): 14-15.
[19] Zheng ZH, Deng XL, Huang YC. Clinical Value of Botulinum Toxin Type a Injection Combined with Physical Therapy for Spasm of Ankle Metatarflexor Muscle Group in Children with Cerebral Palsy [J]. Medical Journal of the PLA, 2020, 32(6): 46-50.
[20] He FP, Du JP, Chen LF, et al. Clinical Observation of Botulinum Toxin a Injection in the Treatment of Children with Cerebral Palsy [J]. Massage and Rehabilitation Medicine (mid-10), 2012, 03(4): 51-51.
[21] Jiang H, Xu KS, Li JL, et al. The Effect of Botulinum Toxin Injection Combined with Functional Training on Gross Motor Function in Children with Spastic Cerebral Palsy [J]. Chinese Journal of Child Health Care, 2008, 16(5): 535-536.
[22] Wu SY. Efficacy of Botox toxin A Assisted Rehabilitation Training in the Treatment of Children with Spastic Cerebral Palsy [J]. Chinese Journal of Clinical Pharmacology & Therapeutics, 2011, 16(12): 1423-1426.
[23] Liu FH. Clinical Observation of 6 Cases of Writing Spasm Treated with Type a Botulinum Toxin [J]. Journal of Stroke and Neurological Disorder, 2001(05): 51.
[24] Yuan GQ, Wang J, Song XP, Liu MX. Clinical Analysis of 92 Cases of Hemifacial Spasm Treated with Type a Botulinum Toxin [J]. Heilongjiang Medical Journal, 2001(03): 184.
[25] You SD, Liu FH. The Effect of Botulinum Toxin a on Blepharospasm in 60 Patients [J]. Chinese Journal of Applied Neurology, 2011, 14(01): 87-88.
[26] Field M, Splevins A, Picaut P, van der Schans M, Langenberg J, Noort D, Snyder D, Foster K. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients. Toxins (Basel). 2018 Dec 13; 10(12): 535.
[27] Li XW, Tian Y, Ma YC. Effect and Safety of Different Concentrations of Botulinum Toxin a in the Treatment of Hemifacial Spasm [J]. Shaanxi Medical Journal, 2019, 48(11): 1545-1547+ 1573.
[28] Lu DW, Lippitz J. Complications of botulinum neurotoxin. Dis Mon. 2009, 55(4): 198-211.
[29] Klein AW. Complications with the use of botulinum toxin. Dermatol Clin. 2004 Apr 22(2): 197-205, vii.
[30] Maanum G, Jahnsen R, Stanghelle JK, Sandvik L, Keller A. Effects of Botulinum Toxin a in Ambulant Adults with Spastic Cerebral Palsy: a Randomized Double-Blind Placebo Controlled- Trial. J Rehabil Med. 2011 Mar; 43(4): 338-47.

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.